By David Carnevali (Reuters) – Private equity firms that deemed drug development too risky for their liking in the past…
Rebounding EM stocks pass “bull market” threshold
LONDON (Reuters) – Fast-charging emerging market stocks were entered so-called “bull market” territory on Monday, as another China-driven surge in…
Eisai, Biogen’s Alzheimer’s drug price should not dent demand – analysts
(Reuters) – The $26,500-per-year price tag for Eisai Co Ltd and Biogen Inc’s newly approved Alzheimer’s disease drug is slightly…
Brazil’s soybean harvest off to slow start -AgRural
SAO PAULO (Reuters) – Harvesting of Brazil’s 2022/2023 soybean crop had reached 0.04% of the national planted area on Thursday…
Ant-linked firms’ shares rise after news of Jack Ma ceding control; Alibaba jumps
(Reuters) -Shares of listed Chinese companies that count Ant Group as a major shareholder rose on Monday after announcements that…
Marketmind: Seeing through another shock
A look at the day ahead in U.S. and global markets from Mike Dolan. Brazil’s weekend political shock reminds world…
Honda’s JV with GAC ends production of Acura brand in China
SHANGHAI (Reuters) – Chinese carmaker Guangzhou Automobile Group (GAC) said on Monday its joint venture with Honda Motor is no…
Russian rouble gains 3% on first working day of 2023
By Jake Cordell (Reuters) – The Russian rouble started the first full trading day of the new year on the…
Analysis-Fall in India nominal GDP growth in FY24 to challenge fiscal math
By Ira Dugal MUMBAI (Reuters) – India’s nominal GDP growth is likely to fall in 2023-24, hurting tax collections and…
Carmaker Stellantis seals batteries material deal with Element 25
MILAN (Reuters) – Carmaker Stellantis has signed a deal with Australian miner Element 25 for the supply of manganese sulphite…